Innate Pharma S.A. (IPHYF)
OTCMKTS · Delayed Price · Currency is USD
2.155
+0.250 (13.12%)
At close: Dec 16, 2025
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of $155.65 million as of February 12, 2026. Its market cap has increased by 1.93% in one year.
Market Cap
155.65M
Enterprise Value
116.50M
Revenue
14.84M
Ranking
n/a
PE Ratio
n/a
Stock Price
$2.16
Market Cap Chart
Since November 1, 2006, Innate Pharma's market cap has increased from 1.01M to 155.65M, an increase of 15,284.34%. That is a compound annual growth rate of 29.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 155.65M | -10.23% |
| Dec 31, 2025 | 173.38M | 4.71% |
| Dec 31, 2024 | 165.58M | -29.08% |
| Dec 29, 2023 | 233.49M | -17.19% |
| Dec 30, 2022 | 281.97M | -29.50% |
| Dec 31, 2021 | 399.94M | 19.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 411.40M |
| CytoDyn | 305.90M |
| Silence Therapeutics | 204.52M |
| HST Global | 139.70M |
| Vaxart | 137.92M |
| BioStem Technologies | 92.40M |
| Nuo Therapeutics | 72.43M |
| VitaSpring Biomedical | 51.78M |